SEC Form 4 · accession 0001171843-18-006603
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Barton Hutt
Director
Period of report
Apr 2, 2018
Accepted (ET)
Sep 18, 2018 · 2:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value per shareF1,F2 | Apr 2, 2018 | A | 3,849 | $0.00 | A | 3,849 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1,F3 | $14.29 | Apr 2, 2018 | A | 6,497 | A | Apr 2, 2019 | Apr 2, 2025 | Common Stock, par value $0.01 per share | 6,497 | 6,497 | D |
Explanation of responses
- F1Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018.
- F2Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer.
- F3The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer.